Autolus Therapeutics PLC (AUTL)

3.34 -0.16 (-4.57%) USD  |  NASDAQ  |  Nov 04, 16:00
3.345 0.00 (0.00%) After-Hours: 20:00
More

Autolus Therapeutics EPS Diluted (Quarterly): -0.22 for June 30, 2024

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Upgrade now.
Date Value
June 30, 2024 -0.22
March 31, 2024 -0.24
December 31, 2023 -0.45
September 30, 2023 -0.26
June 30, 2023 -0.26
March 31, 2023 -0.23
December 31, 2022 -0.23
September 30, 2022 -0.47
June 30, 2022 -0.46
March 31, 2022 -0.41
December 31, 2021 -0.51
Date Value
September 30, 2021 -0.47
June 30, 2021 -0.47
March 31, 2021 -0.53
December 31, 2020 -0.83
September 30, 2020 -0.72
June 30, 2020 -0.62
March 31, 2020 -0.60
December 31, 2019 -0.93
September 30, 2019 -0.61
June 30, 2019 -0.65
March 31, 2019 -0.69

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Quarterly) Range, Past 5 Years

-0.93
Minimum
Dec 2019
-0.22
Maximum
Jun 2024
-0.4689
Average
-0.47
Median
Jun 2021

EPS Diluted (Quarterly) Benchmarks

Adaptimmune Therapeutics PLC 0.24
Biodexa Pharmaceuticals PLC --
NuCana PLC -3.785
TC BioPharm (Holdings) PLC -27.90
Verona Pharma PLC -0.88

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -58.27M
Total Expenses (Quarterly) 58.52M
Enterprise Value 225.39M
Earnings Yield -34.98%
Normalized Earnings Yield -36.11